Please assess the completion status of the following clinical trial:

Trial Title: Mail Order Mifepristone Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Women seeking medication abortion through 63 days gestation~* Eligible for MifeprexⓇ at a study site~* English or Spanish speaking~* Willing and able to participate in the study, including willing and able to receive medications at home or other preferred address within 3 days of initial medication abortion visit~Exclusion Criteria:~* Not pregnant~* Not seeking medication abortion~* under the age of 15~* Over 63 days gestation~* Contraindicated for medication abortion

- Gender: FEMALE
- Minimum Age: 15 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Medication Abortion Patients (Type: EXPERIMENTAL): Oral Mifepristone 200 mg, followed by misoprostol 800 mcg administered buccally (at 24-48 hours following mifepristone)

Based on this trial design, predict the completion outcome and termination type (if applicable).